Promote Risk-Adapted Treatment Strategies for Early Breast Cancer
Dr. Dhanusha Sabanathan discussed the importance of risk-adapted treatment strategies for early breast cancer.
HR+ and HER2- Metastatic Breast Cancer
Professor Hilary Martin discusses HR+ and HER2- metastatic breast cancer
Early stage high risk ER+/HER2- Breast Cancer
Dr. Nick Zdenkowski discusses a case of early-stage, high-risk breast cancer, detailing the patient's diagnosis, treatment plan, and outcomes.
Dr. Sabanathan Case Study
Dr. Dhanusha Sabanathan, a medical oncologist from Sydney, presents cases of metastatic breast cancer, highlighting the effectiveness of the latest medications in treating metaplastic triple-negative breast cancer with minimal side effects.